Abstract
A blogpost on the recent Judgment by the Court of Justice in Case C-179/16, F. Hoffmann-La Roche Ltd e.a. v. Autorità Garante della Concorrenza e del Mercato, 23 January 2018, discussing the Court's application of the competition rules on the relevant market definition and anti-competitive restrictions by object to two medicinal products.
| Original language | English |
|---|---|
| Type | Blogpost |
| Media of output | European Law Blog |
| Number of pages | 5 |
| Publication status | Published - 26-Feb-2018 |
Keywords
- ANTITRUST
- Article 101 TFEU
- Healthcare
- European Law
- Competition law